NYSE:PRGO Perrigo (PRGO) Stock Price, News & Analysis $16.16 -0.08 (-0.46%) Closing price 03:59 PM EasternExtended Trading$16.18 +0.02 (+0.12%) As of 04:01 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Perrigo Stock (NYSE:PRGO) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Perrigo alerts:Sign Up Key Stats Today's Range$16.07▼$16.6750-Day Range$13.47▼$16.9952-Week Range$9.23▼$17.02Volume852,308 shsAverage Volume3.00 million shsMarket Capitalization$2.24 billionP/E RatioN/ADividend Yield7.18%Price Target$18.50Consensus RatingReduce Company Overview Perrigo is a global consumer healthcare company that develops, manufactures and markets over-the-counter medicines and other self-care products. Its offerings include treatments for allergies, coughs and colds, pain and digestive health, as well as skin care, oral care and infant nutrition products. The company supplies both its own consumer brands and store-brand products, which retailers sell under their own labels. Perrigo serves customers primarily in North America and Europe through retail and other healthcare channels. Perrigo traces its roots to a general store opened in Allegan, Michigan, in 1887, where it began supplying medicines. The company is now headquartered in Dublin, Ireland.AI Generated. May Contain Errors. Read More Perrigo Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks40th Percentile Overall ScorePRGO MarketRank™: 2.022941254475 of 5 starsPerrigo scored higher than 40% of companies evaluated by MarketBeat, and ranked 709th out of 877 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.7 / 5Analyst RatingReduce Consensus RatingPerrigo has received a consensus rating of Reduce. The company's average rating score is 1.83, and is based on no strong buy ratings, 1 buy rating, 3 hold ratings, and 2 sell ratings.Upside PotentialPerrigo has a consensus price target of $18.50, representing about 14.3% upside from its current price of $16.18.Amount of Analyst CoveragePerrigo has only been the subject of 3 research reports in the past 90 days.Read more about Perrigo's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings Growth-4.72% Earnings GrowthEarnings for Perrigo are expected to decrease by -4.72% in the coming year, from $2.33 to $2.22 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Perrigo is -1.27, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Perrigo is -1.27, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Growth RatioPerrigo has a PEG Ratio of 1.75. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioPerrigo has a P/B Ratio of 0.76. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Short Interest0.0 / 5Short Interest LevelBearish Percentage of Shares Shorted17.80% of the float of Perrigo has been sold short.Short Interest Ratio / Days to CoverPerrigo has a short interest ratio ("days to cover") of 11.34, which indicates bearish sentiment.Change versus previous monthShort interest in Perrigo has recently increased by 1.79%, indicating that investor sentiment is decreasing. Dividend4.2 / 5Dividend StrengthStrong Dividend LeadershipPerrigo is a leading dividend payer. It pays a dividend yield of 7.17%, putting its dividend yield in the top 25% of dividend-paying stocks.Dividend GrowthPerrigo has been increasing its dividend for 23 years.Dividend SustainabilityBased on earnings estimates, Perrigo will have a dividend payout ratio of 52.25% next year. This indicates that Perrigo will be able to sustain or increase its dividend.Read more about Perrigo's dividend. News and Social Media2.0 / 5News Sentiment0.21 News SentimentPerrigo has a news sentiment score of 0.21. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.59 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 4 news articles for Perrigo this week, compared to 8 articles on an average week.Search Interest16 people have searched for PRGO on MarketBeat in the last 30 days. This is an increase of 129% compared to the previous 30 days. Company Ownership0.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Perrigo insiders have not sold or bought any company stock.Percentage Held by Insiders0.40% of the stock of Perrigo is held by insiders.Percentage Held by Institutions95.91% of the stock of Perrigo is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Perrigo's insider trading history. Receive PRGO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Perrigo and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. PRGO Stock News HeadlinesPerrigo Earnings Call Shows Progress Amid PressureNovember 14 at 10:46 PM | tipranks.comPerrigo Company plc (NYSE:PRGO) Stock Now Rated "Reduce" by Wall Street AnalystsNovember 12, 2026 | americanbankingnews.comBuy Stocks… A Crash is ComingThink stocks are expensive and a crash is coming? Economist Jim Rickards says you're right, but he urges investors not to sell before hearing his 2027 prediction. He warns that by November 30th, Congress is set to make a move he believes will trigger a historic buying panic. Economists call the phenomenon a crack-up boom. Rickards is known for correctly predicting the biggest market shocks of the last 20 years.November 16 at 1:00 AM | Paradigm Press (Ad)Perrigo to Attend the Jefferies Miami Consumer ConferenceNovember 11, 2026 | prnewswire.comHow Investors May Respond To Perrigo (PRGO) Weak 2026 OutlookNovember 7, 2026 | finance.yahoo.comIs Perrigo (PRGO) Undervalued After Its 2026 Sales Guidance Cut?November 7, 2026 | finance.yahoo.comPerrigo: 3 Key Takeaways for Long-Term InvestorsNovember 6, 2026 | fool.comCanaccord Genuity Reaffirms Their Buy Rating on Perrigo Company (PRGO)November 6, 2026 | theglobeandmail.comSee More Headlines PRGO Stock Analysis - Frequently Asked Questions How have PRGO shares performed this year? Perrigo's stock was trading at $13.92 at the start of the year. Since then, PRGO shares have increased by 16.3% and is now trading at $16.1840. How were Perrigo's earnings last quarter? Perrigo Company plc (NYSE:PRGO) issued its quarterly earnings data on Wednesday, November, 4th. The company reported $0.60 EPS for the quarter, beating the consensus estimate of $0.51 by $0.09. The firm's revenue for the quarter was down 5.2% on a year-over-year basis. Read the conference call transcript. Does Perrigo have any subsidiaries? Perrigo subsidiaries include these companies: HRA Pharma, Ranir, Laboratoire de la Mer SAS, Geiss Destin & Dunn, ScarAway, Omega Pharma, Elan Corporation, and others. Who are Perrigo's major shareholders? Perrigo's top institutional shareholders include State Street Corp (6.22%), Edmond DE Rothschild Holding S.A. (1.72%), Sound Income Strategies LLC (1.16%) and Gamco Investors INC. ET AL (0.90%). Insiders that own company stock include Svend Andersen, Eduardo Guarita Bezerra, Robert Willis, Ronald Craig Janish, Patrick Lockwood-Taylor, Geoffrey M Parker, Alison Ives, Katherine C Doyle and Abigail Lennox. View institutional ownership trends. How do I buy shares of Perrigo? Shares of PRGO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Perrigo own? Based on aggregate information from My MarketBeat watchlists, some other companies that Perrigo investors own include Bristol Myers Squibb (BMY), Gilead Sciences (GILD), Teva Pharmaceutical Industries (TEVA), Pfizer (PFE), Tesla (TSLA), Intel (INTC) and SLB (SLB). Company Calendar Record date for 9/15 Dividend8/28/2026Ex-Dividend for 9/15 Dividend8/28/2026Dividend Payable9/15/2026Last Earnings11/04/2026Today11/16/2026Record date for 12/15 Dividend11/27/2026Ex-Dividend for 12/15 Dividend11/27/2026Dividend Payable12/15/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (3m+) 1-Year History Nov 25 Feb 26 May 26 Aug 26 Nov 26 PRGO's financial health is in the Green zone, according to TradeSmith. PRGO has been in this zone for over 3 months. Industry, Sector and Symbol Stock ExchangeNYSE SectorHealthcare Industry Pharmaceuticals Sub-IndustryPharmaceuticals Current SymbolNYSE:PRGO CIK1585364 Webwww.perrigo.com Phone(531) 709-4000Fax269-673-9128Employees8,100Year Founded1887Price Target and Rating Average Price Target for Perrigo$18.50 High Price Target$19.00 Low Price Target$18.00 Potential Upside/Downside+13.9%Consensus RatingReduce Rating Score (0-4)1.83 Research Coverage6 Analysts Profitability EPS (Trailing Twelve Months)($12.76) Trailing P/E RatioN/A Forward P/E Ratio7.32 P/E Growth1.75Net Income-$1.43 billion Net Margins-43.27% Pretax Margin-40.41% Return on Equity12.39% Return on Assets4.07% Debt Debt-to-Equity Ratio1.35 Current Ratio2.35 Quick Ratio1.36 Sales & Book Value Annual Sales$4.09 billion Price / Sales0.55 Cash Flow$5.29 per share Price / Cash Flow3.07 Book Value$21.33 per share Price / Book0.76Miscellaneous Outstanding Shares138,802,000Free Float138,247,000Market Cap$2.25 billion OptionableOptionable Beta0.71 Social Links Don't Wait for the OpenAI IPOThe AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.Get This Free Report This page (NYSE:PRGO) was last updated on 11/16/2026 by MarketBeat.com Staff. From Our PartnersWhat the hell is going on?Porter Stansberry says President Trump is quietly replacing the U.S. dollar without a vote in Congress, and th...Porter & Company | SponsoredManagement just bought 2.8 million sharesManagement just backed a $100 million buyback, repurchasing 2.8 million shares at an average price of $35.26 i...Monument Traders Alliance | SponsoredA little-known law has been quietly applied to your savings for years.Fox News reported that under current law, legal title to most stocks and bonds sits with a central institution...Monetary Gold | SponsoredYour Copy is on Hold (Claim it now)James Altucher, who called NVIDIA in 2008 and SpaceX years before a single share traded, has a new report on E...Paradigm Press | SponsoredThe warning signs most investors see too lateDr. Martin D. Weiss has publicly predicted six major American crashes since founding Weiss Ratings in 1971. ...Weiss Ratings | SponsoredYour dollar buys less every year. Gold's job is different.The U.S. national debt just topped $39 trillion, up nearly $3 trillion in a single year and on pace to hit $40...US Gold Bureau | SponsoredSmall-Cap SMX is Taking its Technology into Multiple Trillion-Dollar Industries!SMX (NASDAQ: SMX) uses proprietary molecular-marking technology and a Digital Material Passport platform to gi...Smallcaps Daily | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Perrigo Company plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Perrigo With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.